Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium

No therapy exists for fetal growth restriction (FGR) due to poor placental function. Current management centers around timing of delivery, balancing the risks of intrauterine demise with those of prematurity due to indicated early birth. Pharmacological intervention to improve placental function may be a way to overcome this dilemma. The international Sildenafil TheRapy In Dismal prognosis Early-onset intrauterine growth Restriction (STRIDER)...